Product news from the 08/22/06 News Brief

Share this article:
Oscient Pharmaceuticals has completed its acquisition of the US rights to the cardiovascular product Antara 130 mg (fenofibrate) capsules from Reliant Pharmaceuticals. Antara will be commercialized by Oscient's national sales force beginning later this week. Bristol-Myers Squibb and Otsuka Pharmaceutical have launched Abilify Discmelt (aripiprazole) orally disintegrating tablets, a new oral form of the antipsychotic medication Abilify (aripiprazole) that disintegrates rapidly in the mouth. The FDA approved Abilify Discmelt in June.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions